Newborn calf serum is an essential growth supplement used in cell culture media for various biopharmaceutical applications. It is extracted from blood collected from newborn calves less than 20 days old and contains a variety of growth nutrients and attachment factors required for cell proliferation and growth. Newborn calf serum finds widespread use in cell-based research for developing therapeutic biologics and vaccines. It is commonly used to culture cells involved in the manufacturing of monoclonal antibodies, recombinant proteins, stem cells, and virus seed stocks. Newborn calf serum acts as a substrate to support cell growth and enhance viability by facilitating cell attachment, spreading, and proliferation.
The Global Newborn Calf Serum Market Size is estimated to be valued at US$ 730 million in 2023 and is expected to exhibit a CAGR of 9.9% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics:
Growing Biopharmaceutical Industry: The biopharmaceutical industry has witnessed significant growth over the past few years on account of rising demand for innovative biologics and therapeutics globally. According to International Federation of Pharmaceutical Manufacturers & Associations, global biopharmaceutical revenues are expected to reach US$ 276 billion by 2026. Growing R&D investments by pharmaceutical companies into cell culture-based methods for developing advanced biologics will augment the demand for newborn calf serum as it is critical for cell proliferation in the bioprocess.
Rising Demand for Therapeutic Monoclonal Antibodies: Monoclonal antibodies have emerged as the most successful biopharmaceutical product class. Increasing approval and adoption of monoclonal antibodies across various disease indications such as cancer, autoimmune disorders, and infectious diseases is driving the growth of this market segment. Newborn calf serum is widely used in the commercial production of monoclonal antibodies as it supports optimal cell growth conditions. Thus, increasing demand for monoclonal antibody therapeutics will propel the newborn calf serum market.
Segment Analysis
The newborn calf serum market can be segmented into serum types and applications. Based on serum types, the fetal bovine serum segment held the largest market share in 2019 as it contains a higher concentration of growth-enhancing factors compared to newborn calf serum. It is widely used in cell culture media for various cell lines. In terms of applications, the biotechnology segment dominated the market in 2019 due to rising demand for newborn calf serum from biotechnology companies for research and cell culture purposes.
PEST Analysis
Political: There are strict norms and regulations regarding the use and handling of newborn calf serum by various regulatory bodies worldwide like FDA in the US and EMA in Europe to ensure safety and humane procedures.
Economic: The global economy is growing at a steady pace leading to higher research & development investments in the biotechnology industry. This will drive the demand for newborn calf serum as it is a key component used in cell culture media formulations.
Social: Growing awareness about animal welfare has led consumers to prefer serum-free and chemically-defined media for cell culture research, which can hamper the market growth to some extent.
Technological: Advancements in cell culture technologies allow the development of serum-free and animal component-free media, which can replace newborn calf serum in the coming years. However, newborn calf serum continues to be the gold standard in cell culture research.
Key Takeaways
The global newborn calf serum market is expected to witness high growth.
Regional analysis: Asia Pacific region is expected to be the fastest growing market for newborn calf serum due to rapid expansion of biotech industry in major economies like China and India along with growing R&D investments. North America dominated the market in 2019 led by the presence of key players and availability of advanced research infrastructure in the region.
Key players operating in the newborn calf serum market are Thermo Fisher Scientific, Merck KGaA, GE Healthcare, Atlanta Biologicals, Tissue Culture Biologicals, Bio-Techne, Biowest, Gemini Bio-Products, Moregate BioTech, Bovogen, Serana, Internegocios, Corning, PAN-Biotech, RMBIO, Biological Industries. Key players operating in the (newborn calf serum) market are Thermo Fisher Scientific, Merck KGaA, GE Healthcare, Atlanta Biologicals, Tissue Culture Biologicals, Bio-Techne.
*Note:
1.Source: Coherent Market Insights, Public sources, Desk research
2.We have leveraged AI tools to mine information and compile it
